These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30173819)
1. Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry. Reidy KJ; Hjorten RC; Simpson CL; Rosenberg AZ; Rosenblum SD; Kovesdy CP; Tylavsky FA; Myrie J; Ruiz BL; Haque S; Mozhui K; Nelson GW; David VA; Yang X; Suzuki M; Jacob J; Reznik SE; Kaskel FJ; Kopp JB; Winkler CA; Davis RL Am J Hum Genet; 2018 Sep; 103(3):367-376. PubMed ID: 30173819 [TBL] [Abstract][Full Text] [Related]
2. Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk. Hong X; Rosenberg AZ; Zhang B; Binns-Roemer E; David V; Lv Y; Hjorten RC; Reidy KJ; Chen TK; Wang G; Ji Y; Simpson CL; Davis RL; Kopp JB; Wang X; Winkler CA Am J Kidney Dis; 2021 Jun; 77(6):879-888.e1. PubMed ID: 33359152 [TBL] [Abstract][Full Text] [Related]
3. Association of preeclampsia with infant APOL1 genotype in African Americans. Miller AK; Azhibekov T; O'Toole JF; Sedor JR; Williams SM; Redline RW; Bruggeman LA BMC Med Genet; 2020 May; 21(1):110. PubMed ID: 32434471 [TBL] [Abstract][Full Text] [Related]
4. Fetal High-Risk APOL1 Genotype Increases Risk for Small for Gestational Age in Term Infants Affected by Preeclampsia. Azhibekov T; Durodoye R; Miller AK; Simpson CL; Davis RL; Williams SM; Bruggeman LA Neonatology; 2023; 120(4):532-536. PubMed ID: 37062283 [TBL] [Abstract][Full Text] [Related]
5. Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry. Thakoordeen-Reddy S; Winkler C; Moodley J; David V; Binns-Roemer E; Ramsuran V; Naicker T Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():129-133. PubMed ID: 32018194 [TBL] [Abstract][Full Text] [Related]
6. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts. Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911 [TBL] [Abstract][Full Text] [Related]
7. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study. Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468 [TBL] [Abstract][Full Text] [Related]
8. Association between Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q Elife; 2023 Oct; 12():. PubMed ID: 37882666 [TBL] [Abstract][Full Text] [Related]
9. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study. Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961 [TBL] [Abstract][Full Text] [Related]
10. Associations between APOL1 genetic variants and blood pressure in African American mothers and children from a U.S. pregnancy cohort: Modification by air pollution exposures. Ni Y; Simpson CL; Davis RL; Szpiro AA; Karr CJ; Kovesdy CP; Hjorten RC; Tylavsky FA; Bush NR; LeWinn KZ; Winkler CA; Kopp JB; Obi Y Environ Res; 2022 Sep; 212(Pt A):113186. PubMed ID: 35358541 [TBL] [Abstract][Full Text] [Related]
11. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease. Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG; J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822 [TBL] [Abstract][Full Text] [Related]
12. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies. Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720 [TBL] [Abstract][Full Text] [Related]
13. APOL1 genotype associated risk for preeclampsia in African populations: Rationale and protocol design for studies in women of African ancestry in resource limited settings. Osafo C; Thomford NE; Coleman J; Carboo A; Guure C; Okyere P; Adu D; Adanu R; Parekh RS; Burke D PLoS One; 2022; 17(12):e0278115. PubMed ID: 36580463 [TBL] [Abstract][Full Text] [Related]
14. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM; Roland MC; Henriksen T; Michelsen TM Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [TBL] [Abstract][Full Text] [Related]
16. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions. Young BA; Blacksher E; Cavanaugh KL; Freedman BI; Fullerton SM; Kopp JB; Umeukeje EM; West KM; Wilson JG; Burke W; Am J Nephrol; 2019; 50(4):303-311. PubMed ID: 31480040 [TBL] [Abstract][Full Text] [Related]
18. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts. Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333 [TBL] [Abstract][Full Text] [Related]
19. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia. Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947 [TBL] [Abstract][Full Text] [Related]
20. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]